Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Celgene Corporation
Scientific Title
A Phase 1B, Open-label, Global, Multicenter, Dose Determination Study to Evaluate Safety, Tolerability, and Preliminary Efficacy of CC-486 (ONUREG) in Combination Therapy in Subjects With Acute Myeloid Leukemia (AML)